Dolby Laboratories (DLB) Cash from Restructuring (2019 - 2020)

Dolby Laboratories (DLB) posted Cash from Restructuring of $8.1 million for Q4 2020, up 3982.91% on a QoQ basis from $199000.0 in Q3 2020, and up 1571.81% year-over-year from $486000.0 in Q4 2019.

Dolby Laboratories (DLB) Cash from Restructuring (2019 - 2020) Analysis & Trends

Dolby Laboratories' Cash from Restructuring history runs 2 years deep, the most recent figure standing at $8.1 million for Q4 2020.

  • Quarterly Cash from Restructuring rose 1571.81% year-over-year to $8.1 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $9.3 million (down 72.5% YoY) and the FY2020 annual result came in at $1.6 million, down 95.07% from the prior year.
  • Cash from Restructuring was $8.1 million for Q4 2020 at Dolby Laboratories, up from $199000.0 in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $27.5 million in Q2 2019 and bottomed at $116000.0 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Cintas 81.31 Bn 81.12 Bn 1.45 Bn
2 Rentokil Initial 73.75 Bn 71.25 Bn -
3 Relx 60.28 Bn 60.04 Bn -
4 Thomson Reuters 38.09 Bn 37.23 Bn -
5 Copart 25.18 Bn 21.85 Bn 732.88 Mn
6 Global Payments 21.29 Bn 16.10 Bn 1.70 Bn
7 Rb Global 20.33 Bn 20.14 Bn 927.90 Mn
8 UL Solutions 17.42 Bn 17.18 Bn 381.00 Mn
9 Aramark 15.00 Bn 14.59 Bn 426.39 Mn
10 Dolby Laboratories 4.68 Bn 4.61 Bn 350.90 Mn

Historic Data

Download Data
DateValue
Dec 25, 2020 8.13 Mn
Sep 25, 2020 199,000.00
Jun 26, 2020 839,000.00
Mar 27, 2020 116,000.00
Dec 27, 2019 486,000.00
Sep 27, 2019 5.79 Mn
Jun 28, 2019 27.46 Mn